Global Trends and Outcomes in Robotic versus Laparoscopic Roux-en-Y Gastric Bypass: A 25-Year Meta-Analysis

Manuscript Summaries

By NATHAN

Published on: 5th Sept 2025

Introduction

Roux-en-Y gastric bypass (RYGB) remains the gold standard bariatric surgery for severe obesity, delivering durable weight loss and remission of metabolic comorbidities such as type 2 diabetes. Over the past 25 years, surgical techniques have evolved from open to laparoscopic (LRYGB), and more recently to robotic-assisted approaches (RRYGB). While laparoscopic surgery has been widely adopted due to benefits like reduced blood loss and shorter hospital stays, robotic surgery offers enhanced precision through seven degrees of instrument articulation, tremor filtration, and magnified 3D visualization. However, the clinical advantages, learning curves, cost-effectiveness, and long-term outcomes of robotic RYGB compared to laparoscopy require comprehensive evaluation to guide practice and policy.

Methods

This PRISMA-compliant meta-analysis synthesizes data from 42 high-quality comparative studies published between 2000 and 2025, incorporating 38,647 patients from 27 countries. The studies included both retrospective and prospective designs, focusing on primary RYGB procedures comparing laparoscopic and robotic approaches. Key outcomes extracted were operative metrics, intraoperative safety, short-term complications, long-term metabolic efficacy, and economic analyses. Statistical methods involved random-effects models for odds ratios (OR) and weighted mean differences (WMD), with heterogeneity and publication bias assessments conducted to ensure robustness.

Results

Temporal and Geographic Trends

  • Temporal Eras: Three distinct phases characterize RYGB surgical evolution:
    • Pioneering Era (2000–2008): 8 studies, 4,215 patients, robotic use 0.2%.
    • Rapid Adoption (2009–2016): 14 studies, 12,893 patients.
    • Contemporary Era (2017–2025): 20 studies, 21,539 patients, robotic use increased to 5.7%.
  • Geographic Distribution: North America leads with 54.8% of studies and 57.4% of patients, followed by Europe (33.3% studies, 29.1% patients) and emerging Asian centers (11.9% studies, 13.5% patients) [[3]][[3]].

Patient Demographics

  • The laparoscopic cohort (95.3%) had a mean age of 42.3 years and BMI of 45.6 kg/m².
  • The robotic cohort (4.7%) had similar demographics with a mean age of 43.1 years and BMI of 46.2 kg/m².
  • Gender distribution was comparable with an overall 72.4% female predominance.

Operative Metrics

  • Operative Time: Robotic RYGB required significantly longer operative times (162.4 ± 28.3 min) than laparoscopic (123.7 ± 19.6 min), a 31.3% increase (~39 minutes; p < 0.001).
  • Learning Curve: Robotic mastery required approximately 50 cases for operative time stability compared to 30 for laparoscopy. The robotic learning curve was biphasic, with rapid improvement in the first 20 cases, followed by gradual refinement [[4]][[4]].
  • Center Volume Effect: High-volume centers (>100 RYGB/year) achieved shorter robotic operative times, with each tenfold volume increase reducing time by 15.7 minutes (p = 0.001).
  • Docking Time: Robotic system docking averaged 14.2 minutes initially, decreasing to 9.3 minutes after 40 cases, with later-generation systems (Xi/X) being 23% faster than earlier models.

Intraoperative Outcomes

  • Blood Loss: Robotic procedures showed a 25.5% reduction in blood loss (82.6 mL vs. 110.9 mL laparoscopic; p < 0.001), especially notable in super-obese (BMI >50) and revisional cases.
  • Conversion Rates: Robotic surgery had a significantly lower conversion to open surgery rate (0.8% vs. 1.1%; OR 0.73; p = 0.03), with a 55.6% reduction in revisional cases.
  • Technical Advantages: Superior visualization and instrument articulation resulted in fewer difficult exposure cases (32% less; p = 0.01), reduced need for additional retraction (41% less; p = 0.003), and lower intraoperative complications, including unintended enterotomies and splenic injuries.

Postoperative Recovery

  • Length of Stay: Robotic patients had shorter hospital stays (2.1 days vs. 2.3 days laparoscopic; p = 0.002), with greater benefit in super-obese and high-risk patients.
  • Pain Management: Opioid requirements were 15% lower in robotic cases, particularly during the first 72 hours, correlating with earlier return of bowel function.
  • Functional Recovery: Patients returned to normal activities 1.2 days earlier after robotic surgery, with better quality of life physical scores at 30 days.
  • Readmissions: Robotic approach was associated with 12% fewer pain-related 30-day readmissions and 19% fewer unplanned outpatient visits.

Safety Outcomes

  • Complications: Major complication rates were similar (4.2% robotic vs. 4.5% laparoscopic; p = 0.61), with comparable mortality (0.06% vs. 0.11%; p = 0.42).
  • Anastomotic Leaks: Slight non-significant trend favoring robotics (1.2% vs. 1.5%; p = 0.14).
  • Infectious and Thromboembolic Events: No significant differences observed.
  • Subgroup Benefits: Robotics reduced pulmonary complications in elderly patients and lowered conversion and blood loss risks in complex cases.

Long-Term Outcomes

  • Weight Loss: Equivalent percentage excess weight loss (%EWL) at 1 year (68.3% robotic vs. 67.1% laparoscopic; p = 0.24) sustained through 5 years (62.4% vs. 60.7%; p = 0.18).
  • Diabetes Remission: Comparable 5-year remission rates (68.2% robotic vs. 65.7% laparoscopic; p = 0.28), with robotic approaches showing superior 15-year remission in select cohorts.
  • GERD Resolution: Robotics demonstrated significantly better outcomes in patients with severe esophagitis (89% vs. 81%; p = 0.02).
  • Chronic Complications: Similar rates for reoperation, internal hernia, anastomotic strictures, and marginal ulcers.

Economic Analysis

  • Initial Costs: Robotic RYGB incurred approximately $1,200 higher procedural costs, driven by equipment and longer operative times.
  • Long-Term Costs: Five-year cumulative costs showed no significant difference after factoring in reduced revision surgeries and late complication admissions.
  • Cost-Effectiveness: High-volume centers achieve faster cost parity; European analyses demonstrated favorable incremental cost-effectiveness ratios (~€8,200/QALY).

Discussion and Clinical Implications

This large-scale meta-analysis confirms that robotic RYGB offers significant intraoperative safety benefits—notably reduced blood loss and lower conversion rates—without compromising long-term weight loss or metabolic outcomes. The robotic approach enhances patient recovery with less pain and quicker return to activities, while maintaining safety comparable to laparoscopy.
The longer operative times and steeper learning curve for robotics are offset by technical advantages particularly relevant in complex, high-risk populations: super-obese patients, revisional surgeries, and those with challenging anatomy. Surgeon experience and high center volumes optimize outcomes and efficiency.
While robotic procedures come at a higher upfront cost, economic analyses suggest parity over five years, emphasizing the importance of selective adoption based on case complexity and institutional resources.
The study highlights the need for:
  • Standardized cost-effectiveness evaluations.
  • Prospective trials utilizing next-generation robotic platforms with AI enhancements.
  • Development of competency metrics beyond operative time for robotic training.
The evidence supports robotic RYGB as a complementary tool rather than a wholesale replacement for laparoscopy, aligning with current international guidelines endorsing robotics for complex bariatric procedures.

Conclusion

Robotic Roux-en-Y gastric bypass, despite longer operative times and a longer learning curve, delivers measurable intraoperative safety advantages, improved postoperative recovery, and equivalent long-term efficacy and safety compared to laparoscopic surgery. These benefits are maximized in experienced hands and high-volume centers, providing critical guidance for surgical training, resource allocation, and the selective integration of robotic technology in metabolic surgery.

SOURCE/READ THE FULL ARTICLE: https://pubmed.ncbi.nlm.nih.gov/40911141/

 


LEARN MORE ABOUT THE MUSLIM WEIGHT MANAGEMENT

 

Share this post